Skip to main content

Table 2 The total and category-based costs in Iranian rial (PPP $) from perspective of the patients

From: Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis

 

Total costs (million)

Direct costs (million)

Direct medical costs (million)

Direct nonmedical costs (million)

Indirect costs (million)

5th percentile

5.5 (421.1)

1.4 (10.57)

0 (0)

0 (0)

2.2 (168.44)

95th percentile

2.700 (20,511.21)

1.900 (14,231.46)

1.800 (13,909.9)

1.30 (1019.81)

2.90 (2224.91)

Median

2.20 (1667.54)

1.40 (1088.72)

1.20 (900.38)

1.8 (13.78)

6.6 (505.32)

IQR

4.30 (3265.4)

4.40 (3369.52)

3.80 (2871.1)

1.5 (114.84)

6.6 (505.32)

Mean

6.90 (5265.98)

5.20 (3959.03)

4.90 (3772.64)

2.4 (186.4)

1.70 (1306.95)

SD

1.700 (12,776.12)

1.300 (10,200.95)

1.300 (10,192.81)

6.3 (484.69)

9.50 (7272.97)

  1. IQR Interquartile range, SD Standard deviation